Apoptotic and autophagic cell death have been implicated, on the basis of morphological and biochemical criteria, in neuronal loss occurring in neurodegenerative diseases and it has been shown that they may overlap. We have studied the relationship between apoptosis and autophagic cell death in cerebellar granule cells (CGCs) undergoing apoptosis following serum and potassium deprivation. We found that apoptosis is accompanied by an early and marked proliferation of autophagosomal-lysosomal compartments as detected by electron microscopy and immunofluorescence analysis. Autophagy is blocked by hrIGF-1 and forskolin, two wellknown inhibitors of CGC apoptosis, as well as by adenovirusmediated overexpression of Bcl-2. 3-Methyladenine (3-MA) an inhibitor of autophagy, not only arrests this event but it also blocks apoptosis. The neuroprotective effect of 3-MA is accompanied by block of cytochrome c (cyt c) release in the cytosol and by inhibition of caspase-3 activation which, in turn, appears to be mediated by cathepsin B, as CA074-Me, a selective inhibitor of this enzyme, fully blocks the processing of pro-caspase-3. Immunofluorescence analysis demonstratesd that cathepsin B, normally confined inside the lysosomal-endosomal compartment, is released during apoptosis into the cytosol where this enzyme may act as an execution protease. Collectively, these observations indicate that autophagy precedes and is causally connected with the subsequent onset of programmed death.
Extensive and premature cell loss in specific neuronal populations by programmed cell death (PCD) is the main pathological hallmark of neurodegenerative diseases (Jellinger and Stadelmann 2000) . Although PCD can manifest in many forms, two major kinds of PCD have been proposed (Schwartz et al. 1993; Zakeri et al. 1995) . Type I PCD, or classical apoptosis, is a highly controlled process. It involves a series of well-characterized morphological changes that include loss of cell volume, chromatin condensation, cell blebbing and nuclear fragmentation. At the biochemical level, a cohort of proteases termed caspases contributes to the execution phase of this process (Hengartner 2000) .
Type II PCD, on the other hand, is morphologically characterized by increased autophagy and early destruction of the cytoplasm, which either precedes nuclear pyknosis or occurs in its absence (Schweichel and Merker 1973; Clarke 1990; Zakeri et al. 1995) .
Autophagy consists of a rate-limiting sequestration of cytoplasmic material into double-membrane, autophagic vacuoles derived from the endoplasmic reticular membranes. The vacuole that is formed (the autophagosome) fuses with a prelysosomal compartment where degradation, by lysosomal enzymes, occurs (Klionsky and Emr 2000) . This pathway is known to be important in normal cellular homeostasis for the replacement of obsolete organelles and proteins, and in the maintenance of cell function during periods of nutrient deprivation. However, recent studies have shed light on the importance of autophagy in both normal development (Schwartz et al. 1993; Zakeri et al. 1995) and in pathological conditions (Jeffrey et al. 1992; Stefanis et al. 2001) .
In this latter regard, the vigorous activation of both the neuronal lysosomal system and cellular pathways converging on the lysosomes are prominent neuropathological features anticipating the cell shrinkage in Alzheimer's disease, Huntington disease, scrapie and Creutzfeldt-Jakob disease (CJD; Nixon et al. 2001) .
Although apoptosis and autophagy are morphologically distinct forms of programmed cell death, recent evidence has suggested that autophagy may coexist with apoptosis (Hengartner 2000) or may precede it in a process that is induced by apoptotic stimuli (Xue et al. 1999; Guimaraes et al. 2003) . Several autophagy-associated proteins, such as cathepsin D, APG5 and cathepsin B are involved in different paradigms of apoptosis in vitro (Deiss et al. 1996; LevyStrumpf and Kimchi 1998; Isahara et al. 1999; Foghsgaard et al. 2000; Guicciardi et al. 2000; Kagedal et al. 2001) . To date the relationship between these two forms of cell death is not known.
We have investigated this relationship in CGCs undergoing apoptosis following serum and potassium withdrawal.
Our study revealed that serum and potassium depletion triggers autophagosome proliferation and points to cathepsin B as a possible mediator of caspase-activation in CGCs undergoing apoptosis.
Materials and methods
Ac-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin (Ac-DEVD-MCA) (00000-3-methyladenine) and Ac-Val-Glu-Ile-Asp-7-amido-methylcoumarin (Ac-VEID-MCA) was from Biomol (Plymouth Meeting, PA, USA). MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys (Dnp) gamma-NH2 was from Peptide International (Louisville, KY, USA). Z-Arg-Arg-MCA was from Sigma (St. Louis, MO, USA). 3-Methyladenine (3-MA), Monodansylcadaverine (MDC), Pepstatin A and forskolin were from Sigma. CA074-Me, zFA-fmk and zVADfmk were from Calbiochem (La Jolla, CA, USA). Rabbit-anticleaved caspase-3 (Asp175); anti-phospho Akt (Ser473); anti-phospho c-jun; anti-pan jun; anti-p-p38; anti-ERK1/2 and anti-p-ERK1/2 were from Cell Signalling Technology (New England Biolabs Ltd, Beverly, MA, USA). Rabbit anti-phospho-pan-JNK, sheep anticytochrome c and mouse anti-b-actin and anti-tubulin were from Sigma-Aldrich. The rabbit anti-rat cathepsin B Ig was a gift of Dr John S. Mort (McGill University, Montreal, Quebec, Canada) . The rabbit anti-LC3 Ig was a gift of Dr T. Yoshimori (Department of Cell Biology, National Institute for Basic Biology, Okazaki, Japan).
Mouse anti-Lamp-1 was from StressGen Biotechonologies Corp (Victoria, BC, Canada) . Mouse anti-COX-IV was from Molecular Probes, Eugene, OR, USA. Human recombinant IGF1 (hrIGF1) was from Boheringer GmbH, Mannheim, Germany.
Cell cultures
Cultures enriched in granule neurons were obtained from dissociated cerebella of 8-day-old Wistar rats (CGC; Charles River, Calco, Italy), as described by Levi et al. (1984) . Cells were plated in basal medium Eagle (BME; Life Technologies, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum, 25 mM KCl, and 2 mM glutamine (Life Technologies, Gaithersburg, MD, USA) on dishes (Nunc, Roskilde, Denmark) coated with poly-L-lysine. Cells were plated at 2.5 · 10 6 per 35 mm dish or 7 · 10 6 per 60 mm dish. 1b-Arabinofuranosylcytosine (10 lM) was added to the culture medium 18-22 h after plating to prevent proliferation of non-neuronal cells.
Induction of apoptosis
Cultures at 6-7 days in vitro (DIV) were washed two times and switched to serum-free BME containing 5 mM KCl (S-K5) supplemented with glutamine and gentamicin. Control cells were washed with BME and maintained in serum-free medium containing 25 mM KCl (S-K25) (D'Mello et al. 1993) .
Assessment of neuronal viability
Viable CGCs were quantified by counting the number of intact nuclei in a haemacytometer, after lysing the cells in detergent-containing solution (Soto and Sonnenschein 1985; Volontè et al. 1994 ). This method has been shown to be reproducible and accurate and to correlate well with other methods of assessing cell survival-death (Stefanis et al. 1997; Stefanis et al. 1999) . Cell counts were performed in triplicate and are reported as means ± SEM. The data are expressed as the percentage of intact nuclei in the control cultures at each time point. Viable CGCs were also quantified by the MTT tetrazolium salt assay (Manthrope et al. 1986 ) to ensure that the nuclear counts reflected functionally active neurons. Briefly, MTT tetrazolium salt (0.25 mg/mL) was added to neurons grown in 24-well plates and incubated for 1-2 h at 37°C. The reaction media were then gently aspirated, and isopropanol containing 0.08 M HCl was added to solubilize the formazan product. Formazan/isopropanol mixtures were then transferred to 96-well plates and quantified using Multiskan plate reader at 570 nm (Labsystem Multiskan MCC/340 (Labsystems, Helsinki, Finland)). Moreover, Hoechst nuclear staining was used to detect typical chromatin changes (Hoetchst 33258, Sigma, St. Louis, MO, USA). Cells were fixed with phosphate-buffered saline (PBS) containing 4% paraformaldehyde for 20 min, permeabilized with 0.1% Triton X-100-Tris/Cl, pH 7.5 for 5 min, then washed two times with PBS. After incubation with Hoechst 33258 (0.5 mg/mL in PBS), neurons were washed two times with PBS. Coverslipes were photographed using UV by microscope; apoptotic neurons were characterized by scoring condensed nuclei.
Overexpression of Bcl-2 in cerebellar granule cells Four days after plating, control adenovirus (Ad-bgal) or adenoviral GFP-Bcl-2 (provided by Dr Marco Crescenzi, ISS, Roma) at 30 multiplicity of infection (MOI) were used to transduce CGCs as described by Amadoro et al. 2004 . CGCs were then further cultured up to 6 DIV when experiments were performed.
Transmission electron microscopy (TEM)
Neurons were fixed, at 4°C for 1 h with 2.5% glutaraldhyde in 0.1 M Millonig's phosphate buffer (MPB; to obtain 100 mL, mix 32 mL 2 M sodium dihydrogen orthophosphate, 14 mL 2 M disodium hydrogen orthophosphate, 50 mL double-distilled water, pH 7,4) containing 2% sucrose, and then post-fixed for 1 h at 4°C with 1% OsO 4 in the same buffer. After washing in MPB cells were dehydrated in ascending ethanol concentrations and embedded in Spurr epoxy resin (Agar Scientific Ltd., Stansted, UK). Ultrathin sections were stained with uranyl acetate and lead citrate and observed under a Philips CM12 transmission electron microscope operating at 80 kV.
Visualization of MDC-labelled vacuoles
Visualization of MDC labelled vacuoles were performed as described by (Biederbick et al. 1995) . In brief, autophagic vacuoles were labelled with 50 lM monodansylcadaverine (MDC) by incubating neurons grown of coverslips at 37°C for 10 min. After incubation, cells were washed four times with PBS, fixed in 4% paraformaldehyde (w/v in PBS) for 15 min. After fixation, cells were washed three times with PBS and analysed using an Olympus optical microscope equipped with a filter system (excitation filter, 340-380 nm, barrier filter, 430 nm).
Immuofluorescence CGCs were fixed with for 15 min at 22°C, washed in PBS, pH 7.5, and then permeabilized with 0.1% Triton X-100 and Tris/Cl, pH 7.5, for 5 min. The coverslips were treated with polyclonal antibody against LC3 (1 : 100) and Lamp-1 (1 : 300) or with polyclonal antibody against cathepsin B (1 : 600) or with polyclonal antibody against cytochrome c (1 : 600) in a moist chamber overnight at 4°C, rinsed in PBS, and stained with FITC and/or tetramethyl-rhodamineisothiocyanate (TRITC)-conjugated secondary antibodies (Sigma) for 30 min. Nuclei were stained with Hoechst 33528.
Confocal Laser Scanning Microscopy (CLSM)
Fluorescently labelled samples were imaged by a confocal LEICA TCS 4D microscope (Leica, Heidelberg, Germany) equipped with 100 · 1.3-0.6 oil-immersion objective (optical section, 0.5, 1 lM).
Images of double-labelled samples were recorded with simultaneous excitation and detection of both dyes to ensure proper image alignment. The excitation and emission wavelengths were 488 nm and 510 nm, respectively, for FITC-labelling, and 568 nm and 590 nm, respectively, for TRITC-labelling. Optical sections were stereopaired and reconstituted in three dimensions. To correct for possible cross-talk resulting from overlapping excitation and emission spectra of the dyes used, when necessary, recorded images were corrected using the MULTICOLOR analysis package software by Leica. Proteolytic activities of cathepsin B and D CGCs were lysed in 50 mM Tris/HCl, pH 7.5, 0.15 M NaCl, and 1% Triton for 30 min on ice and then centrifuged at 1250 g for 20 min. The activity of cathepsin B was assayed using the z-Arg-Arg-MCA (Sigma) as substrate according to the method of Barret and Kirschke 1981) , while that of cathepsin D was assayed using the fluorogenic substrate MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys (Dnp) gamma-NH2 (Peptides International) as described by Yasuda et al. (1999) .
Nucleosomal formation assay

Measurement of cytosolic cathepsin B activity
To measure cathepsin B activity in the cytosol, cytosolic fractions were prepared as described previously (Nakayama et al. 2002) with minor modifications. Pellets were resuspended in extraction buffer (250 mM sucrose, 50 mM HEPES, 1 mM pefablock and 10 mg/mL leupeptin). After 10 min on ice, neurons were lysed with a glass dounce homogenizer with 10 strokes, followed by centrifugation at 750 g for 10 min at 4°C to remove nuclei and unbroken cells. Supernatants were then centrifuged at 15 000 g for 30 min to remove lysosomes and mitochondria. The resultant supernatants were further centrifuged at 100 000 g for 1 h at 4°C and the final supernatants (cytosolic fractions) were collected. Cathepsin B activity was estimated as described above according to the method of Barret and Kirsche (1981) .
Fluorogenic peptide substrate assay for caspase activities Caspase-3 activity was measured, as described previously (Canu et al. 2000) . After 8 h of incubation in S-K5, 500 000 granule cells were washed once with PBS and lysed in 100 lL of buffer A (10 mM HEPES pH 7.4, 42 mM KCl, 5 mM MgCl 2 , 1 mM dithiothreitol (DTT), and 1 mM PMSF, 0.5% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulphonic acid (CHAPS), and 1 mg/ mL leupeptin). Lysate (25 lL) was combined with 75 lL of buffer B (25 mM HEPES, 1 mM EDTA, 0.1% CHAPS, 10% sucrose, and 3 mM DTT pH 7.5) containing 30 lM Ac-DEVD-MCA and incubated for 20 min at 22°C. Caspase-6 activity was measured, as described previously (Allsopp et al. 2000) , combining 40 lL of lysate from buffer A with 200 lL of buffer B (25 mM HEPES/KOH pH 7.5, 50 mM NaCl, 1 mM EDTA, 5 mM EGTA, 2 mM MgCl 2 0.1% CHAPS, 10% sucrose, and 10 mM DTT) containing 20 lM of caspase-6 fluorogenic substrate Ac-VEID-MCA and incubated at 37°C for 30 min. Fluorescence was measured at an excitation of 380 nm and an emission of 460 nm wavelengths using a Packard Fluorocount microplate reader (Packard Bioscience Company, Meriden, CT, USA).
Western blot analysis
Equal amounts of proteins were subjected to SDS-PAGE on 10% gels. After electroblotting to nitrocellulose (Hybond-C), proteins were visualized using appropriate primary antibodies. All primary antibodies were diluted in 0.5% (w/v) non-fat dry milk and incubated with the nitrocellulose blot overnight at 4°C. Incubation with secondary peroxidase-coupled anti-mouse or anti-rabbit Igs was performed at room temperature for 45 min. Immunoreactivity was detected by the enhanced chemiluminescence (ECL) reaction (Amersham).
RT-PCR experiments
Total RNA (3 lg/lL), extracted from CGCs and PC12 was retrotranscribed, using random hexamers, by Molony murine leukaemia virus reverse transcriptase. The template produced from the RT reaction was amplified using the following primers: 5¢-GATGGCCCAGAACCTTGTGG-3¢ sense and 5¢-CCAGCCGGAGGTTGAATGTC-3 antisense, which would be expected to produce PCR product sizes of 383 base pairs (bp). The nested PCR was performed with the sense 5¢-CAAGGTGG-CTCAGGCAGTGA-3¢ starting at 879 and the antisense primer above, which would be expected to produce a PCR product of 325 bp. For the PCR reaction, 29 lL of H 2 O, 5 lL of 10· PCR buffer, 4 lL of MgCl 2 (25 mM), 1 lL of dNTP (10 mM of each), 0.5 lL of Taq DNA polymerase (5 U/lL), 0.25 lL of both the relevant oligonucleotide primers (50 lM), and 5 lL cDNA reaction (or, for the control, 5 lL of the RT reaction in which reverse transcriptase had been omitted) were added to each tube to give a final volume of 50 lL. The PCR reaction was run on a GeneAmp PCR system 9600 (Perkin-Elmer/Cetus, Norwalk, CT, USA) at 94°C for 1 min, followed by 40 cycles of 94°C for 30 s, 56°C for 30 s, 72°C for 45 s.
Results
Activation of autophagy in CGCs undergoing apoptosis
Rat CGCs can be induced to undergo apoptosis if the potassium concentration is reduced to 5 mM (K5) and serum is removed (S-) after a period of initial growth in 25-30 mM potassium (K25) and serum (S+) (Galli et al. 1995; D'Mello et al. 1993 Gallo et al. 1985 . This form of cell death has been described as apoptotic or PCD type 1 because it is dependent on macromolecular synthesis, is accompanied by DNA fragmentation and is temporarily prevented by the pan caspase-inhibitor, z-VAD-fmk (D'Mello et al. 1993; Nardi et al. 1997; Canu et al. 2000) . In fact, we found that this substance delays but does not irreversibly block death of these neurons (N. Canu, unpublished observations). This observation raised the possibility that KCl and serum deprivation may trigger an alternative mechanism of cell death as also suggested by other reports (Miller et al. 1997; Tanabe et al. 1998) . To gain insights into this issue, we examined the ultrastucture of CGCs during the commitment phase (0-6 h) (Galli et al. 1995) of apoptosis. As visualized by electron microscopy the morphology of control CGCs included big nuclei with fine dispersed chromatin and a normal complement of healthy mitochondria and endoplasmic reticulum (Figs 1a and b, arrow) . In contrast, CGCs exposed to 6 h of serum and KCl deprivation displayed large electron-dense membranous whorls and vacuoles in the cytoplasm and in the neurites. Vacuoles were more abundant in neurons with the earliest apoptotic alteration in nuclear morphology (e.g. condensation of nuclear morphology into electron dense packed material along the nuclear membrane) and with condensed mitochondria and cytoplasm (Figs 1c, e and f) (Hacker 2000) . These vacuoles, 600 Å in diameter, resembled autophagosomes based on the presence of a double membrane and the nature of the contents, which appeared to consist of cytoplasmic structures at different stages of digestion (Fig. 1d) . In apoptotic neurons, at 6 h of apoptosis, the number of autophagosomes was 6 ± 1.45 (mean ± SEM) per cell section, while in control neurons the number of vacuoles was 1.3 ± 0.97 (mean ± SEM). As apoptosis progressed in these cultures the number of autophagosome declined. This could reflect their progressive fusion with lysosomes (not shown).
As a first attempt to follow the autophagic activation during the progression of apoptosis, we used the autofluorescent drug monodansylcadaverine (MDC), a specific autophagolysosome marker (Biederbick et al. 1995; Munafo and Colombo 2001) . As shown in Fig. 1g , control neurons displayed very faint, dispersed basal MDC staining, but serum and KCl deprived neurons appeared to be filled progressively with rounded MDC labelled structures throughout the soma and neurites (Fig. 1g ). This vacuolization, which appears very shortly after the apoptotic stimulus, was also detected by immunofluorescence analysis using an antibody against LC3 (microtubule-associated protein light chain 3) a selective marker of autophagosomes (Kabeya et al. 2000) . LC3, the mammalian homologue of the yeast autophagy gene Aut7/Apg8, is a soluble cytoplasmic protein in cells growing in normal conditions, but it becomes membrane associated under starving conditions. In control CGCs, the LC3 immunofluorescence pattern was diffuse but became punctate after 1-3 h of KCl and serum withdrawal (Fig. 2) , similar to findings reported previously (Kabeya et al. 2000) .
The LC3 punctuate staining was present only in the early phase of apoptosis and, as reported previously (Kabeya et al. 2000) never overlapped with Lamp-1 (a marker of lysosomes). At the later time-points LC3 punctate staining became negligible during a period in which the vacuoles became almost uniformly Lamp-1 positive, suggesting that all autophagosomes had fused to lysososmes (Fig. 2) . Given that the autophagosomes may fuse with the endocytic compartment before fusing with lysosomes (Stromhaug and Seglen 1993) we cannot rule out the possibility that LC3, reported as a specific marker of autophagosomes (Kabeya et al. 2000) can also label the autophagic vacuoles formed by the fusion between autophagosome and endosomes (Liou et al. 1997 ). This possibility is presently under investigation.
Autophagy is blocked by IGF-1 and Forskolin
We and others have reported previously that hrIGF-1 and forskolin, two drugs that work on two different but correlated signal transduction pathways, are powerful inhibitors of CGCs apoptosis (D'Mello et al. 1993; Galli et al. 1995; Miller et al. 1997) . As different stimuli can induce both autophagy and apoptosis in vitro (Isahara et al. 1999; Xue et al. 1999; Zaidi et al. 2001) we investigated the effect of these substances in regulating autophagosome formation in CGCs apoptosis. For this purpose immunofluorescence analysis was performed 6 h after apoptosis induction in the absence or presence of hrIGF-1 (25 ng/mL) or forskolin (10 lM). As shown in Fig. 3a , hrIGF-1 and forskolin block the autophagosome proliferation as well as cell death assessed 24 h after apoptosis induction.
Autophagy is Bcl-2 dependent and caspase-independent It has been reported that down-regulation of Bcl-2 expression resulted both in apoptotic and autophagic cell death (Saeki et al. 2000; Zaidi et al. 2001) . In order to dissect the molecular pathway leading to activation of autophagy, we investigated the effect of adenovirus-mediated overexpression of Bcl-2 on this system. For this purpose, CGCs were transducted at 4 DIV with Ad-GFP-Bcl-2 coding vector and with control Ad-bgal vector. After 48 h, neurons were induced to undergo apoptosis for 6 h and analysed by immunofluorescence with LC3 staining. In neurons overexpressing Ad-GFP-Bcl-2 and undergoing apoptosis (Fig. 3b) , the proliferation of autophagosome compartment was blocked while apoptotic neurons, overxpressing control Ad-bgal, displayed a large increase in the number of autophagosomes. It must be pointed out that under these conditions Bcl-2 overexpression protects CGCs from death as documented by the number of viable cells; confirming a previous report (Watson et al. 1998) . Furthermore, as shown in Fig. 3c , CGCs undergoing apoptosis and treated with the pan-caspase inhibitor z-VAD-fmk exhibited a similar number
(g) of autophagic particles as the control cells, as demonstrated by immunofluorescence analysis with the LC3 antibody. This finding indicates that inhibition of caspase does not affect autophagosome activation, and that autophagosome formation plays a caspase-independent role in the pathway leading to death of CGCs.
Inhibition of autophagy protects CGCs from cell death
To understand the role of autophagy in apoptosis, we treated CGCs undergoing apoptosis with 3-methyladenine (3-MA), a widely used, inhibitor of autophagy in mammalian cells (Seglen and Gordon 1982) . This inhibitor was added to the culture medium before or at the time of apoptosis induction. Neuronal survival was determined 24 h later by the MTT assay, by counting the number of intact nuclei as described previously (Volontè et al. 1994; Stefanis et al. 1997; Stefanis et al. 1999) (Figs 4a and b) and by scoring the apoptotic nuclei by Hoechst 33528 staining (Fig. 4c) . As reported in Figs 4a, b and C and 3-MA was a very effective inhibitor of cell death, maintaining 100% survival at 24 h. At later times the neuronal viability decreased to 80% of control. To confirm that 3-MA indeed blocked autophagy, CGCs were analysed by immunofluorescence with the anti-LC3 Ig. As shown in Fig. 4d , CGCs induced to undergo apoptosis in the presence of 3-MA showed an LC3 immunostaining pattern almost indistinguishable from that of control cells, and no LC3 positive vacuoles were observed. This finding indicates that 3-MA effectively prevents the formation of autophagosomes. We found that treatment of CGCs with either 20 or 10 mM 3-MA prevented both autophosome proliferation and cell death, without affecting neuronal morphology nor protein synthesis (data not shown). Therefore, 10 mM was the concentration chosen for the further studies.
3-MA does not promote survival by activating Akt or suppressing stress kinases activation or by stimulating purinergic receptors In order to establish if the antiapoptotic effect of 3-MA was due to modulation of the pro-survival pathways induced by depolarization (Miller et al. 1997 Neuronal apoptosis and autophagic-lysosomal system 1233 et al. 1999) or of certain stress killer kinases elicited in CGCs by potassium and serum deprivation (Watson et al. 1998) we investigated the effect of 3-MA on PI-3 kinase (phosphatidylinositol-3-kinase)-Akt, ERKs, p38, JNK kinases and on p-c-Jun. The kinase activity of Akt is sustained by phosphorylation on Ser473. This site is rapidly dephosphorylated after induction of apoptosis by potassium deprivation (Dudek et al. 1997; Miller et al. 1997) . Interestingly, although the extent of phospho-Akt was markedly reduced during apoptosis, the addition of 3-MA increased this reduction (Fig. 5a ) to the extent that the band was no more visible. Such a negative trend was still observed after 24 h of apoptosis (not shown). Notice that during the same period the amount of total Akt was unchanged (Fig. 5a ). Akt dephosphorylation was also observed in potassium-maintained neurons treated with 3-MA (not shown). Moreover, 3-MA had a little effect on the decrease in ERK 1/2 phosphorylation seen following serum and potassium deprivation (Villalba et al. 1997; Harris et al. 2002) , nor did it affect the increased phosphorylation of SAP/JNK and p38 kinases (Watson et al. 1998; Yamagishi et al. 2001; Harris et al. 2002) as well as of their target c-Jun occurring during apoptosis (Fig. 5a ). It is worth mentioning that the state of ERK phosphorylation during apoptosis depends upon the timeschedule of apoptotic induction as when this event is triggered at 4 DIV instead than at 6 DIV, as in these experiments and in other deprivation studies, (Villalba et al. 1997; Harris et al. 2002) an increase has been reported (Subramaniam et al. 2003) .
We have shown previously that adenosine and ADP, via interaction with A 1 and P2X receptors, respectively, markedly inhibited the program of cell death in CGCs (Vitolo et al. 1998) . As it has been reported that adenosine and ADP are robust inhibitors of hepatocytic autophagy (Samari and Seglen 1998) we investigated whether 3-MA exerted its neuroprotective role by acting through purinergic receptors. A range of concentrations of DCPX (an A 1A receptor antagonist) and suramine (a non-competitive antagonist of P2X, P2Y receptors) were added to the culture medium of CGCs undergoing apoptosis in the presence or absence 3-MA, and neuronal survival was determined 24 h later. Neither DPCPX nor suramine were able to block the neuroprotective effect of 3-MA (Fig. 5b) , suggesting that 3-MA does not act via purinergic receptors. Altoghether these findings suggest that 3-MA acts downstream of these apoptotic pathways. Fig. 3 Effects of antiapoptotic factors on autophagy: (a) CGCs were induced to undergo apoptosis for 6 h in the absence or in the presence of hrIGF-1 (25 ng/mL) or forskolin (10 lM) and were processed for LC3 immunostaining. Notice that hrIGF-1 and forskolin abolish the punctate immunostaining of LC3, indicating that they block its association with the membrane vacuoles. (b) CGCs were infected at 4 DIV with either b-gal or Bcl-2-expressing adenovirus vectors at MOI 30. At 6 DIV neurons were induced to undergo apoptosis for 6 h, and then analysed by scanning laser microscopy after immunostaining with anti-LC3 antibody. Notice that overexpression of Bcl-2 markedly reduces the number of LC3 positive vacuoles. (c) Immunofluorescence localization of LC3 in CGCs induced to undergo apoptosis for 6 h in the absence (S-K5) or in the presence of 100 lM z-VAD-fmk (S-K5 + z-VAD-fmk). z-VAD-fmk does not eliminate the punctate immunostaining of LC3, nor does it prevent autophagosome formation. Scale bar: 7 lm. The corresponding viability, assessed at 24 h after apoptosis induction, for the different experimental conditions is reported below each figure. 3-MA inhibits morphological and biochemical features of apoptosis To ascertain whether the neuroprotective effect of 3-MA was correlated with the inhibition of known hallmarks of serum and KCl deprivation-induced apoptosis, we assessed the extent of DNA laddering, reactive oxygen species (ROS) production and caspase activation (Schulz et al. 1996) . Figure 6a shows that DNA cleavage induced in CGCs by serum and KCl deprivation, measured by an ELISA measuring internucleosomal DNA fragmentation assay, was completely abolished by 3-MA treatment of apoptotic CGCs.
ROS have been implicated as important effector molecules in apoptotic cell death (Hockenbery et al. 1993; Kane et al. 1993) and are reported to be released in large amount from CGCs (Atlante et al. 2003) . ROS production was evaluated with the oxidation-sensitive indicators DCF-H2, a lipophilic nonfluorescent indicator that is oxidized by ROS to the fluorescent dye DCF. As shown in Fig. 6b , the indicator detected a peak in DCF fluorescence at 4 h after apoptosis, whose appearance was largely blocked in cells treated with 3-MA.
DNA fragmentation and ROS production occur downstream of caspase activation (Schulz et al. 1996) . Among caspases, caspase-3 is a key component of CGC's apoptosis (Eldadah et al. 1997; Canu et al. 2000) . Therefore, we examined the possible involvement of 3-MA in the regulation of caspase-3 activity. As shown in Fig. 6c , caspase-3 like activity was approximately 10-fold elevated in apoptotic neurons with respect to control (S-K25) neurons. In contrast, neurons treated with 3-MA and subjected to apoptotic stimuli exhibited an almost undetectable activation. Moreover, addition of 10 or 20 mM 3-MA to apoptotic cell lysate did not reduce caspase-activity, indicating that 3-MA operates by blocking caspase activation rather than caspase-3 activity. Neurons were lysed and analysed by immunoblot for phospho-Akt (p-Akt), phospho-ERK1/2 (p-ERK) and for the total amount of both enzymes (a, left panel). p-SAP/JNK, phospho-p38 (p-p38), phosphoc-Jun (p-c-jun) and pan-Jun were labelled with specific antibodies (a, right panel). Amounts of loaded proteins were controlled for homogenity by probing the membrane with an anti-b-actin mAb. Results show a representative experiment that was repeated three times. (b) CGCs were induced to undergo apoptosis for 24 h in the absence or in the presence of 3-MA (10 mM) plus different amounts of DPCPX and suramine. Neuronal survival was determined using an MTT assay. Results are means (± SEM) of duplicate determinations from three independent experiments and are reported as percentage of control cells (S-K25 for 24 h).
This conclusion was further supported by assessing the effect of 3-MA on pro-caspase-3 processing. By exploiting an antiserum that specifically recognizes the cleaved, active form of caspase-3, we found that neurons induced to undergo apoptosis were strongly immunostained (Fig. 6d, arrows) whereas neurons treated with 3-MA were barely immunolabelled, consistent with the conclusion that pro-caspase-3 protein remained uncleaved.
Inhibition of caspase-6 activity by CP-VEID-cho, prevents caspase-3 activation in granule neurons undergoing apoptosis (Allsopp et al. 2000) , and we therefore investigated its activity in 3-MA treated neurons. As reported in Fig. 6e , caspase-6 activity in neurons treated with 3-MA was identical to that of control cells, while apoptotic neurons displayed an approximately twofold increase 1 h after the onset of apoptosis (Allsopp et al. 2000) . Taken together, these studies strongly suggest that inhibition of autophagic activity suppresses the pathway leading to the activation of caspase-3-like proteases rather than directly inhibiting these enzymes.
3-MA prevents cytochrome c release
The intrinsic (mitochondrial) death pathway plays through the release of mitochondrial cytochrome c (cyt c), an important role in CGCs apoptosis (Bobba et al. 1999) . To determine whether inhibition of autophagosome formation prevented the intrinsic apoptotic pathway, the release of cyt c was investigated by Western blotting analysis of cytosolic and mitochondrial fraction. As shown in Fig. 6f , cyt c was released in the cytosol of CGCs induced to undergo apoptosis for 3 h as reported previously by Bobba et al. (1999) . Addition of 3-MA during apoptosis markedly diminished the release of cyt c from mitochondria to cytosol. Thus, 3-MA inhibits the release of cyt c from mitochondria and the subsequent activation of caspases.
The autophagosomal/lysosomal compartment controls caspase-3 activation through cathepsin B 3-MA stops macro-autophagy at the sequestration step in mammalian cells (Seglen and Gordon 1982) , so we asked whether inhibition at different steps would prevent cell death and/or relieve specific apoptotic features such caspase activation.
Inhibitors of autophagy acting downstream of the sequestration phase, such as bafilomycin A(1), a specific inhibitor of vacuolar H (+)-ATPase, and inhibitors of the cathepsin D and L (pepstatin and z-FA fmk) were not able to block the death process at 24 h (Fig. 7a) nor did they suppress caspase activity (Fig. 7c) . In contrast, CA074-Me, a selective inhibitor of cathepsin B (Buttle et al. 1992 ) was able to delay cell death and to interfere with caspase activation (Fig. 7b) . In the presence of this drug neurons remained alive for 12-15 h. At later time points, the neuroprotective effect was less evident (Fig. 7a) and at longer time points it was not more detectable (not shown), probably because in the presence of this compound autophagic activity remains elevated (Fig. 7b) . Nevertheless, inhibitors of cathepsin B were able to prevent caspase-3 activation. Z-FA-fmk and CA074-Me did not appear to inhibit the activity of preactivated caspase-3 as addition of these compounds to lysates of apoptotic CGCs, at the time of substrate addition, did not inhibit DEVD-MCA hydrolysis (Fig. 7C) . Instead, they appear to act by inhibiting caspase Fig. 6 3-MA inhibits the appearance of apoptotic markers. (a) CGCs were induced to undergo apoptosis for 10 h in the absence or in the presence of 3-MA (10 mM), and DNA fragmentation was measured as described in Material and methods. Data are the mean (± SEM) (n ¼ 3). (b) 10 mM 3-MA inhibits ROS production detected by dihydrorhodamine 123 fluorescence measured 4 h after apoptosis. Results are reported as the mean (± SEM) (n ¼ 4). (c) Eight hours after apoptosis in the presence or absence of 3-MA (10 mM) neurons were lysed and assayed for DEVD-MCA cleavage. (d) CGCs were immunostained with an antibody against cleaved caspase-3 (Asp175) (red) and counterstained with the DNA dye Hoechst for nuclei (white). Notice that 3-MA fully inhibits caspase-3 activity (c) and activation (d) into the cytoplasm of apototic neurons (arrows indicate change in caspase-3 positive neurons). Scale bar: 7 lm. (e) Caspase-6 activity was measured 1 h after apoptosis using the fluorogenic substrate VEID-MCA. Fold-induction of caspase-3 and caspase-6 activities are the means (± SEM) of triplicate determinations from three independent experiments. (f) Western blot analysis of cyt c. Either cytosolic or respective mitochondrial fraction from CGCs, induced to undergo apoptosis for 3 h in the absence or in the presence of 3-MA (10 mM), were analysed by Western blotting analysis. An antibody against mitochondrial COX-IV was used as a marker of mitochondrial contamination of cytosolic extracts and as control of protein loading/ transfer.
activation. This latter conclusion was further corroborated by finding that both z-FA-fmk and CA074-Me were able to prevent pro-caspase 3 activation, as shown by immunofluorescence analysis performed with an antibody that specifically recognized cleaved caspase-3 (Asp175) (Fig. 7d) .
We next determined the proteolytic activity of lysosomal cathepsin D and B. Cathepsin D was measured by incubating the cell lysates with the fluorogenic substrate MOAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys (Dnp)g-NH2. This substrate is hydrolysed equally by cathpesin D and E (Yasuda et al. 1999) . It has been reported that cathepsin E is barely, if at all, expressed in cerebellum (Yasuda et al. 1999 ) and we similarly failed to detect cathepsin E mRNA in CGCs by RT-PCR (Fig. 7e) . Therefore, the enzymatic activity tested in these lysates by this assay is likely to reflect cathepsin D alone. Cathepsin B activity was measured by incubating the cell lysates with the cathepsin B specific substrate Z-Arg-Arg-MCA (Barret and Kirschke 1981) .
While the activity of cathepsin D was only slightly modulated during the progression of apoptosis, that of cathepsin B rapidly increased reaching 150% of its initial activity 6 h after the onset of apoptosis, when it drastically declined to 80% of its initial activity at 24 h (Fig. 7f) . Cathepsin B is synthesized as a proenzyme and is transported into lysosomes where it is processed into active forms, a two-chain form (25-27 kDa) and a single-chain form (29-31 kDa). As can been seen in Fig. 7g , the amount of the precursor and the mature forms of cathepsin B increased in the first 6 h of apoptosis, and declined thereafter.
Cathepsin B is relocated from lysosomes to the cytoplasm during apoptosis The finding that inhibition of cathepsin B blocked caspase-3 activation, raised the question of how an enzyme normally confined to the endolysosomal compartment could be involved in the activation of the caspase cascade that, to date, is reported to take place in the cytosol. One possibility is that cathepsin B translocates into the cytosol during apoptosis, as also reported in other in vitro models of apoptosis (Guicciardi et al. 2000) . In order to assess this hypothesis, we used immunofluorescence and Western blot analysis to visualize the cellular distribution of cathepsin B in CGCs. As shown in Fig. 8a , cathepsin B exhibited a pronounced punctate staining in control cells, consistent with its lysosomal localization. After induction of apoptosis, an increase in cathepsin B immunostaning was observed, in agreement with data reported in Fig. 7f , and the staining became diffusely distributed in the cytoplasm of apoptotic neurons, recognizable as those having Hoechst-positive nuclei (Fig. 8a,  arrow) . It is noteworthy that co-immunostaining of the lysosomes with mAb against Lamp-1 showed a punctate immunolabelling that did not disappear during apoptosis, indicating that the lysosomal membranes were still preserved when cathepsin B is present in the cytosol (Fig. 8b) . Further evidence of translocation of cathepsin B is indicated by immunoblot analysis showing that the cathepsin B active fragments (p30 and p27) increased in the cytosol of CGCs induced to undergo apoptosis (Fig. 8c) . Thus, these results are consistent with a translocation from a vesicular compartment into the cytosol, or to an altered trafficking of cathepsin B during apoptosis. We found that, when CGCs were induced to undergo apoptosis in the presence of the cathepsin B inhibitor CA074-Me, cathespin B translocation was not prevented (Figs 8d and e) , suggesting that the loss of lysosome membrane integrity or function is not cathepsin B-dependent. Similar results were also obtained when CGCs were treated with lipid peroxidation inhibitors (data not shown).
We next addressed the question of whether cathepsin B was active in the cytosol of apoptotic neurons. As shown in Fig. 8d , cytosolic cathepsin B activity was detected as soon as 3 h after KCl withdrawal and reached a maximum at 6 h when it started to decline (Fig. 8f) . Given the emerging role of cathepsin B in regulating caspase-3 activation and activity, we performed a double-immunostaining for both proteins and we found that cathepsin B and activated pro-caspase-3 colocalized in the cytosol of apoptotic neurons (Fig. 8g) . This finding further underlines the potential significance of cathepsin B translocation in caspase activation.
Discussion
In the present work we provide evidence for the activation of an autophagic process within the context of the apoptotic program of CGCs. In particular, we have established a causal role of autophagosomal/lysosomal compartment, via cathepsin B, in the activation of the caspase-cascade and provide evidence that autophagy may mediate a program of caspaseindependent cell death.
Cultured CGCs deprived of depolarizing concentrations of potassium are one of the most widely employed model for the investigation of neuronal apoptosis. Although it has been reported previously that this manipulation causes classical apoptotic cell death (D'Mello et al. 1993) , the data presented in this paper suggest that the situation is more complex and that this type of death is geared with autophagy.
Activation of the autophagosome/lysosomal compartments, monitored by electron microscopy, MDC labelling and LC3 and Lamp-1 immunostaining (Figs 1 and 2 ) occurs very early after induction of apoptosis, before the classical apoptosis morphology is manifested (Fig. 2) . These degradative compartments expanded with time, and were most abundant in cells that also contained fragmented or pycnotic nuclei. Several findings suggest that the existence of two populations of cells (undergoing apoptotic and autophagic death, respectively) is unlikely. Thus, it is worth noting that autophagosomes were more abundant in cells with the earliest nuclear and cytoplasmic alteration of apoptosis (Fig. 1c) . Moreover, the full protection exterted by the antiautophagic 3-MA points to an homogeneous population (Figs 3 and 6) . Therefore, we favour the hypothesis, presently under investigation, that there is a transition within each cell from autophagic to an apoptotic process.
While the mechanism of autophagy induction in CGCs remains to be established we found that it is was fully prevented by hrIGF-1 and forskolin and by overexpression of Bcl-2. It has been reported stimulation of class I PI-3 kinase activity inhibits, whereas class III PI-3 kinases induce, autophagic sequestration (Petiot et al. 2000) . As far as IGF-1 is concerned, it is probable that it inhibits autophagy by regulating the phosphorylation state of the PI-3-kinases of class I. Forskolin acts by increasing the intracellular concentration of cAMP, whose role in inhibiting the sequestration phase of autophagy has been reported (Holen et al. 1996) .
Members of the Bcl-2 family play an important role in programmed cell death in the developing brain (Kuan et al. 2000) . Recent data also supported an involvement of these factors in autophagic cell death. In fact, Bcl-XL deficiency induced, and Bax deficiency inhibited, chloroquine-induced cell death of cortical neurons (Zaidi et al. 2001) . Moreover, antisense-mediated down regulation of Bcl-2 in leukaemia cells caused an extensive autophagic cell death (Saeki et al. 2000) . Our data are in line with these studies, as overexpression of Bcl-2 largely inhibited the proliferation of the autophasomal compartment and protected CGCs from death. How this effect is achieved remains to be elucidated. It is possible that the interaction of Bcl-2 with beclin-1 is involved. Beclin-1, the mammalian homologue of yeast Apg6 gene, induces autophagy (Liang et al. 2001) complexing with the trans-Golgi network (Kihara et al. 2001) . During CGCs apoptosis a functional depletion of Bcl-2 occurs, due to down-regulation of antiapoptotic Bcl-2 proteins (Alavez et al. 2003) and, in particular, to up-regulation and mislocalization of proapoptotic Bcl-2 proteins (Harris and Johnson 2001; Putcha et al. 2002) . Therefore, it is tempting to speculate that beclin-1 could be released from the Bcl-2/beclin-1 complex thus activating autophagy by interacting with PI3-kinase. However, further investigations are required to explore this hypothesis.
Our study demonstrates that, in this model of neuronal death, induction of autophagy is caspase-independent. In fact, caspase-3 activation occurs downstream of, and appears to depend upon, induction of autophagy. Thus, we found that 3-MA was able to protect caspase-inhibited neurons from delayed cell death (data not shown). This observation suggests that, once activated, autophagy actively contributes to channel CGCs to death. Previous studies have attributed a critical role in apoptosis to autophagy; a process triggered by NGF deprivation in sympathetic neurons (Xue et al. 1999) ; serum deprivation in PC12 cells (Isahara et al. 1999) ; chloroquine in cortical neurons (Zaidi et al. 2001) and by brief ischemia in CA1 pyramidal neurons in the gerbil hyppocampus (Nitatori et al. 1995) , by N-methyl-D-aspartate in organotypic hippocampal cultures (Borsello et al. 2003) or by tamoxifen in human mammary carcinoma cells (Bursch 2001) .
Likewise, inhibition of autophagy in CGCs by 3-MA, prevented both cell death and autophagosome proliferation.
3-MA did not induce activation of Akt indicating that this pathway does not contribute to CGC protection. Moreover, the neuroprotective effect of 3-MA did not involve the supression of JNK pathway nor the activation of purinergic receptors, previously reported to exert a neuroprotective effect against apoptosis (Vitolo et al. 1998) . Altogether these findings suggest that the steps inhibited by 3-MA lie further downstream. Given the role of Bcl-2 in suppressing autophagy, it is tempting to speculate that 3-MA may act on the same steps that are postulated to initiate autophagy likely at the level of PI-3 kinase/Bcl-2 complex. Thus, 3-MA leads to inhibition of the release of cytochrome c from mitochondria into the cytosol, therefore preventing activation of the active form of caspase 3 ( Fig. 6a  and b) , and of other caspases.
To better understand the role of autophagy in the activation of caspases, we pharmacologically inhibited the autophagy downstream of the sequestration phase. We found that, only inhibitors of cathepsin B were able prevent caspase-activation and to exert a transitory vital role (Figs 7a, c and d) . It is probable that the lack of long-terminal survival is due to the persistence of autophagic activity in CGCs treated with cathepsin inhibitor (Fig. 7b) . This situation mimicks that of caspase-inhibited CGCs (Fig. 6c) .
Cathepsins have been implicated in a number of important cellular processes such as protein degradation, antigen presentation and cell death. We showed, that the activation and translocation of cathepsin B was a crucial event in CGCs undergoing apoptosis, as reported recently for TNF-triggered apoptosis (Foghsgaard et al. 2000; Guicciardi et al. 2000) , and for TWEAK-induced cell death (Nakayama et al. 2002) . The finding that translocation of cathepsin B was not prevented by cathepsin B inhibitor (Fig. 8) nor by inhibitors of lipid peroxidation (not shown) suggests that other factors are responsable for the lack of lysosomal membrane integrity.
Given that autophagy requires the dynamic mobilization of cellular membranes and specialized protein machinery we can not rule out the possibility that an altered sorting of lysosome enzymes may occur during apoptosis. Whatever the mechanism that underlies cathepsin B translocation, the finding that CGCs were protected by the cathepsin B inhibitor CA074-Me, even though cathepsin B was still translocated to the cytosol, indicates that this process is not necessarily detrimental to cell viability, per se. The importance of cathepsin B has been demonstrated previously in studies of animals deficient in the endogenous cathepsin B inhibitor, cystatin B, which suffer a drastic loss of CGCs by apoptosis (Houseweart et al. 2003) . In our in vitro experiments, it is possible that cystatin activity is lost, therefore allowing cathepsin B to initiate and propagate the execution phase of apoptosis. It remains to be investigated whether this phase involves cathespin B-mediated release of cyt c in the mitochondrial death pathway or, alternatively, proceeds via direct or indirect activation of caspase, as suggested recently (Stoka et al. 2001) .
